Navigation Links
New insights into the fate of antiparasitics in manure and manured soils

In recent years, there has been growing interest in the question, if the entry of veterinary medicinal products (VMP) into soils via manure application is of environmental relevance. In a recent study, published in the November issue of the journal CLEAN, Kreuzig and co-workers now focused on the so far less investigated benzimidazole antiparasitics, adding valuable data to the so far available data set on fate and behavior of veterinary medicinal products in manure and manured soils.

An innovative experimental design for laboratory tests on VMP has been developed in order to simulate the real entry route of VMP into soil environments already under laboratory conditions. Degradation tests of VMP as 14C-labeled radiotracers in manures were conducted. On this basis, test manures containing 7-day aged VMP residues were prepared and then applied in laboratory batch tests to study degradation and sorption of VMP in manured soils. In further tests, the differentiation of microbial, chemical and photoinduced degradation were taken into account. Finally, test-plot experiments were performed under field conditions to monitor the transferability of the laboratory data to field conditions.

The benzimidazole antiparasitics flubendazole and fenbendazole mainly remained extractable in pig manure and soil samples. Antibiotics like sulfonamides, in contrast, rapidly formed non-extractable residues. Flubendazole was found unchanged while fenbendazole was accompanied by corresponding metabolites. Due to their slow degradation in pig manure, the manure storage is not considered to reduce substantially the environmental exposure. As shown by the sorption tests, both benzimidazoles did not fulfill the criteria of potential leachers. Finally, the degradation tests showed the dependence of the metabolic fate on the microbial activity in soil and on the test-manure application. These aspects, therefore, emphasized that the consideration of manure effects already under laboratory conditions supports a better understanding of the environmental fate of VMP under field conditions.


Contact: Vera Koester

Related biology news :

1. Stomach stem cell discovery could bring cancer insights
2. KGI professor contributes new insights on jumping genes
3. Study involving more than 100 scientists provides new insights on green algae
4. New insights into how lasers cut flesh
5. Tumor genome analysis unveils new insights into lung cancer
6. Manure management reduces levels of antibiotics and antibiotic resistance genes
7. CU researcher engineers sorghum that grows in poisonous soils
8. Chemical compound present in detergents produce bacteria alterations in agricultural soils
Post Your Comments:
(Date:6/9/2016)... 2016 Paris Police Prefecture ... security solution to ensure the safety of people and operations ... the major tournament Teleste, an international technology group ... announced today that its video security solution will be utilised ... up public safety across the country. The system roll-out is ...
(Date:6/2/2016)... , June 2, 2016 ... Manned Platforms, Unmanned Systems, Physical Infrastructure, Support & Other ... provider visiongain offers comprehensive analysis of the ... this market will generate revenues of $17.98 billion in ... acquired DVTEL Inc, a leader in software and hardware ...
(Date:5/12/2016)... , May 12, 2016 , ... published the overview results from the Q1 wave of ... recent wave was consumers, receptivity to a program where ... with a health insurance company. "We were ... share," says Michael LaColla , CEO of Troubadour ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... Epic Sciences unveiled a liquid biopsy ... PARP inhibitors by targeting homologous recombination deficiency (HRD) ... test has already been incorporated into numerous clinical ... Over 230 clinical trials are investigating ... PARP, ATM, ATR, DNA-PK and WEE-1. Drugs targeting ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a leader in clinical ... Patient Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits ... tips, tools, and strategies for clinical researchers. , “The landscape of how patients ...
(Date:6/23/2016)... TORONTO , June 23, 2016 /PRNewswire/ - ... Ontario biotechnology company, Propellon ... the development and commercialization of a portfolio of ... cancers. Epigenetic targets such as WDR5 represent an ... contribute significantly in precision medicine for cancer patients. ...
(Date:6/23/2016)... MA (PRWEB) , ... June 23, 2016 , ... ... Peel Plate® YM (Yeast and Mold) microbial test has received AOAC Research Institute ... platform of microbial tests introduced last year,” stated Bob Salter, Vice President of ...
Breaking Biology Technology: